Active Investments

Aeglea Biotherapeutics

Private

Akari Therapeutics

Private

Audentes Therapeutics

Private

AveXis

Private

KalVista Pharmaceuticals

Private

REGENXBIO

Public (NASDAQ: RGNX)

Replicor

Private

Avalanche Biotech

Public (NASDAQ: AAVL)

DBV Technologies

Public (NYSE: DBV)

Ocera Therapeutics

Public (NASDAQ: OCRX)

Alumni Investments

Juno Therapeutics

Public (NASDAQ: JUNO)

Ardea Biosciences

Acquired by AstraZeneca

BioCryst Pharmaceuticals

Public (NASDAQ: BCRX)

Dyax

Public (NASDAQ: DYAX)

Keryx Biopharmaceuticals

Public (NASDAQ: KERX)

Medivation

Public (NASDAQ: MDVN)

Neurocrine Biosciences

Public (NASDAQ: NBIX)

NPS Pharmaceuticals

Public (NASDAQ: NPSP)

Vanda Pharmaceuticals

Public (NASDAQ: VNDA)

YM Biosciences

Acquired by Gilead

Bong Koh Partner

Focus Areas: Biotechnology
Location: New York

Bong originally joined Venrock in 2009 and has been doing public and private investing since 2004. He did his medical training at Harvard’s Mass Eye & Ear Infirmary (ophthalmology), Stanford Hospital (internal medicine) and UCSF (pathology).

Bong is a manager of Venrock’s public and cross-over biotech fund, Venrock Healthcare Capital Partners, where he provides leadership in biotech investments.

On the private side, Bong led Venrock’s investments in Aeglea Biotherapeutics, Akari Therapeutics (PIPE), Avalanche Biotechnologies (series B), Audentes Therapeutics (series B), AveXis (pre-mezzanine and series D), Juno Therapeutics (series A), KalVista Pharmaceuticals, REGENXBIO (series C & D) and Replicor (first institutional investor round).

Bong is on the AveXis’ board of directors and is an observer at REGENXBIO Inc., KalVista Pharmaceuticals and Audentes Therapeutics.

Bong earned his B.A. from Yale University, his M.D. from the University of California, San Francisco, and an M.B.A. from Harvard Business School.

Active Companies

Aeglea Biotherapeutics

Akari Therapeutics

Audentes Therapeutics

AveXis

KalVista Pharmaceuticals

REGENXBIO

Replicor

Avalanche Biotech

DBV Technologies

Ocera Therapeutics

Alumni Companies

Juno Therapeutics

Ardea Biosciences

BioCryst Pharmaceuticals

Dyax

Keryx Biopharmaceuticals

Medivation

Neurocrine Biosciences

NPS Pharmaceuticals

Vanda Pharmaceuticals

YM Biosciences